Premium
Propanc Biopharma Inc (PK) (PPCB)
USOTC
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. The Company's novel proe... Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. The Company's novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body's primary defense against cancer. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 11.9997 | 3999900 | 0.0003 | 0.0003 | 0.0002 | 11312894 | 0.00023366 | CS |
| 12 | 11.99975 | 4799900 | 0.00025 | 0.0004 | 0.0002 | 9173171 | 0.00030396 | CS |
| 26 | 11.9996 | 2999900 | 0.0004 | 0.00065 | 0.0002 | 9008320 | 0.00036831 | CS |
| 52 | 11.99575 | 282252.941176 | 0.00425 | 0.0064 | 0.0002 | 13577942 | 0.00103484 | CS |
| 156 | -9 | -42.8571428571 | 21 | 41.4 | 0.0002 | 20891639 | 1.05017251 | CS |
| 260 | -69.5 | -85.2760736196 | 81.5 | 700 | 0.0002 | 14851825 | 1.92229361 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
